ARTHROPLASTY
Tranexamic acid effectively reduces blood loss after TKA without adverse events
This report has been verified
by one or more authors of the
original publication.
Knee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1849-58
The purpose of this review was to determine the comparative efficacy between systemic and topical routes of tranexamic acid administration, optimal doses and timings, and the safety considerations of its use. 28 randomized controlled trials comparing the efficacy and safety of tranexamic acid use after total knee arthroplasty were included in this systematic review. Findings revealed both systemic and topical administrations reduced blood loss after total knee arthroplasty without increasing the incidence of symptomatic deep-vein thrombosis and pulmonary embolism.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
